BioCentury
ARTICLE | Clinical News

Apoptone: Additional Phase I/IIa data

October 4, 2010 7:00 AM UTC

Data from 22 chemotherapy-naïve patients in an ongoing, open-label Phase I/IIa trial showed that 100 or 350 mg/day Apoptone produced 20 cases of stable disease at 8 weeks, with 1 confirmed partial res...